Completed
NA
INTERVENTIONAL
NCT06779994
The Safety and Efficacy of Probiotic for Improving Intestinal and Immune Function
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
To evaluate the safety and efficacy of Streptococcus salivarius subsp. thermophilus ST36 in healthy adults on immune function and intestinal health.
Interventions
Name:
Probiotic
Type:
DIETARY_SUPPLEMENT
Description:
The experimental phase of this study will last 8 weeks and each subject will have three visits (day 0, week 4 and week 8).
Name:
Placebo
Type:
DIETARY_SUPPLEMENT
Description:
The experimental phase of this study will last 8 weeks and each subject will have three visits (day 0, week 4 and week 8).
Primary Outcomes
Measure:
Antimicrobial peptide levels in stool samples
TimeFrame:
8 weeks
Description:
Antimicrobial peptides refer to fecal calprotectin and LL-37(Cathelicidin Antimicrobial Peptide). The change in their concentrations at the end of the intervention was detected compared to baseline.
Trial Information
NCT ID
NCT06779994
Status
Completed
Study Type
INTERVENTIONAL
Phases
NA
Sponsor
Wecare Probiotics Co., Ltd.
Last Updated
December 15, 2025